CYP2D6 inhibition not only reduces the formation of M1, it also increases tramadol parent drug plasma concentrations, which may be associated with an increased risk of the potentially life-threatening, dose-dependent serotonin syndrome [43]. Here, CYP2D6 is linked to serotonin syndrome.